Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

Abstract Background Remdesivir is being studied and used to treat coronavirus disease 2019 (COVID-19). This study aimed to systematically identify, critically evaluate, and summarize the findings of the studies on the cost-effectiveness of remdesivir in the treatment of hospitalized patients with CO...

Full description

Bibliographic Details
Main Authors: Aziz Rezapour, Zahra Behroozi, Mostafa Nasirzadeh, Mohsen Rezaeian, Mohammad Barzegar, Mahsa Tashakori-Miyanroudi, Abdollah Sayyad, Aghdas Souresrafil
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Infectious Diseases of Poverty
Subjects:
Cost-effectiveness
Remdesivir
COVID-19
SARS-CoV-2
Online Access:https://doi.org/10.1186/s40249-023-01092-1

Internet

https://doi.org/10.1186/s40249-023-01092-1

Similar Items